Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Net Issuance of Common Stock
Theravance Biopharma Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Net Issuance of Common Stock
-$199.6m
|
CAGR 3-Years
-200%
|
CAGR 5-Years
-90%
|
CAGR 10-Years
N/A
|
See Also
What is Theravance Biopharma Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-199.6m
USD
Based on the financial report for Mar 31, 2024, Theravance Biopharma Inc's Net Issuance of Common Stock amounts to -199.6m USD.
What is Theravance Biopharma Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-90%
Over the last year, the Net Issuance of Common Stock growth was -7%. The average annual Net Issuance of Common Stock growth rates for Theravance Biopharma Inc have been -200% over the past three years , -90% over the past five years .